The COVID-19 Self-Testing Through Rapid Network Distribution (C-STRAND) Trial: A Randomized Controlled Trial to Increase COVID-19 Testing in Underserved Populations
Overview
Authors
Affiliations
Background Widely available population testing is critical to public health efforts to control the ongoing COVID-19 pandemic. However, COVID-19 testing has been low in underserved communities disproportionately affected by COVID-19. One approach to increase testing rates is through the secondary distribution of self-collection kits, where an individual distributes test kits to contacts in their social network and encourages them to self-collect test specimens. We outline a randomized clinical trial, COVID-19 Self-testing Through Rapid Network Distribution (C-STRAND), and a cohort study of individuals with COVID-19, to determine the impact of a secondary distribution strategy on COVID-19 testing among medically underserved populations. Methods The clinical trial will seek to enroll 1048 adult index participants from federally health qualified centers in Philadelphia, PA seeking COVID-19 testing. Eligible participants will be randomized 1:1 to receive multiple self-collection test kits or multiple referrals for standard clinic-based tests to distribute to contacts within their social network. The primary outcome will be testing among at least two network contacts at 8 weeks. Index participants and network contacts who test positive for COVID-19 from C-STRAND will be eligible to join the COVID-19 Close Contact Self-testing Study (CloseST), assessing the secondary distribution of self-collection test kits among individuals with COVID-19. The primary outcome of this cohort will be the number of close contacts who test positive at 8 weeks. Conclusion Novel strategies to promote COVID-19 testing are necessary, particularly among underserved populations most affected by COVID-19. We will determine the efficacy of a self-testing secondary distribution strategy. The results may inform efforts to increase testing rates during the current pandemic.
Salient beliefs related to secondary distribution of COVID-19 self-test kits within social networks.
Bien-Gund C, Sarbaugh M, Perrine L, Dugosh K, Gross R, Fishman J Front Public Health. 2024; 12:1337745.
PMID: 38476496 PMC: 10927981. DOI: 10.3389/fpubh.2024.1337745.
Anand A, Vialard F, Esmail A, Khan F, OByrne P, Routy J PLOS Glob Public Health. 2024; 4(2):e0002336.
PMID: 38324519 PMC: 10849237. DOI: 10.1371/journal.pgph.0002336.
Shi F, Zhang J, Yang X, Gao H, Chen S, Weissman S AIDS Behav. 2023; 28(Suppl 1):22-32.
PMID: 38109020 DOI: 10.1007/s10461-023-04244-4.
Qasmieh S, Robertson M, Teasdale C, Kulkarni S, Jones H, Larsen D Commun Med (Lond). 2023; 3(1):92.
PMID: 37391483 PMC: 10313770. DOI: 10.1038/s43856-023-00321-w.